Three Months Ended

Nine Months Ended

June 30,

June 30,

2023

2022

2023

2022

Net income (loss)

$

6,314,204

$

(22,195,576)

$

(69,320,881)

$

(42,753,412)

Basic weighted average common shares outstanding

88,266,152

80,088,431

83,218,748

80,054,594

Net effect of dilutive instruments:

Stock options

25,962

—

—

—

Stock appreciation rights

9,402

—

—

—

Common stock purchase warrants

—

—

—

—

Total net effect of dilutive instruments

35,364

—

—

—

Diluted weighted average common shares outstanding

88,301,516

80,088,431

83,218,748

80,054,594

Net income (loss) per basic common share outstanding

$

0.07

$

(0.28)

$

(0.83)

$

(0.53)

Net income (loss) per diluted common share outstanding

$

0.07

$

(0.28)

$

(0.83)

$

(0.53)